Environmental determinants of KSHV transmission in rural Uganda
乌干达农村 KSHV 传播的环境决定因素
基本信息
- 批准号:9765819
- 负责人:
- 金额:$ 48.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-07 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:4 year oldAcuteAddressAdultAfrica South of the SaharaAgeAge-MonthsBiological AssayBloodBlood specimenCancer BurdenCancer EtiologyCellsChildChildhoodClinicalCross-Sectional StudiesCytometryDataDetectionDiagnosisEnrollmentEnvironmentEnvironmental Risk FactorEpidemicEpidemiologyFrequenciesFutureGenderGeneral PopulationGeographyHIVHealthHerpesviridaeHerpesviridae InfectionsHomeostasisHumanHuman Herpesvirus 8ImmuneImmune responseImmunosuppressive AgentsInfantInfectionInflammatoryKaposi SarcomaKnowledgeLeadLocationLongitudinal StudiesMalariaMeasuresMolecularMolecular EpidemiologyMonitorOncogenicOutcomeParasitemiaParasitesPathogenesisPhenotypePlasmaPlasmodium falciparumPopulationPredispositionPrevalencePreventionPublishingReportingResearchResourcesRiskRisk FactorsRoleRuralSalivaSamplingSeroprevalencesTestingUgandaVariantViralViral Load resultWhole BloodWorkbasecellular targetingcohortcytokinefollow-upimmune functionmalaria infectionmalaria transmissionmonocyteperipheral bloodpopulation basedprogramsprospectiveseroconversionseropositivetherapy developmenttransmission processtrend
项目摘要
PROJECT SUMMARY/ABSTRACT
Kaposi's sarcoma-associated herpesvirus (KSHV), the causative agent of Kaposi's sarcoma (KS), is
unique among human herpesviruses in that it is not ubiquitous in human populations, but rather shows marked
geographic hotspots in prevalence, being particularly common in sub-Saharan Africa (SSA). Moreover, there is
variation in prevalence even between geographically proximate locations within the same population in SSA.
This strongly suggests the presence of modifiable environmental factors that facilitate and maintain high levels
of transmission in SSA and we posit that malaria infection is a key underlying factor. We provide extensive
published and preliminary data supporting an interaction between malaria infection in children and KSHV
seroprevalence. We hypothesize that malaria infection in children increases their susceptibility to KSHV
through alterations in immune function or expansion of KSHV cellular targets or both. For children that are
already KSHV infected, malaria infection could lead to viral reactivation resulting in higher viral loads in
peripheral blood, higher frequency of shedding or both. The General Population Cohort (GPC) in rural Uganda
is a longitudinal study investigating the trends and determinants of the HIV epidemic, as well as non-
communicable disease risk factors. We found that KSHV seroprevalence in the GPC is among the highest ever
reported (>90%) and children are infected at an early age (~30% by 3 years). The early age of KSHV infection,
the endemic malaria transmission and the high levels of KSHV seroprevalence in the Ugandan GPC provides
us with a unique opportunity to directly test our hypothesis. We will do this by enrolling a prospective infant
cohort within the GPC determining the effect of P. falciparum on the establishment of KSHV infection;
characterizing immune phenotype in children prior to KSHV infection and evaluate effects of P. falciparum on
KSHV reactivation. In this proposal, we will capitalise on an ongoing substantive research program on KSHV
and will embed the proposed work within a long-standing population-based cohort in rural Uganda, with a
substantial body of existing data. The proposed work will address the profound knowledge gap regarding
factors that influence KSHV transmission. This may, in the future, lead to the development of interventions to
reduce transmission and thereby reduce the burden of KS.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROSEMARY ROCHFORD其他文献
ROSEMARY ROCHFORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROSEMARY ROCHFORD', 18)}}的其他基金
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
EB 病毒和疟疾对伯基特淋巴瘤病因学的协同作用
- 批准号:
10319534 - 财政年份:2019
- 资助金额:
$ 48.92万 - 项目类别:
The synergistic contributions of EBV and malaria to the etiology of Burkitt lymphoma
EB 病毒和疟疾对伯基特淋巴瘤病因学的协同作用
- 批准号:
9887039 - 财政年份:2019
- 资助金额:
$ 48.92万 - 项目类别:
Micronutrient Malnutrition and EBV Persistence in Children
儿童微量营养素营养不良和 EBV 持续存在
- 批准号:
7587370 - 财政年份:2008
- 资助金额:
$ 48.92万 - 项目类别:
Micronutrient Malnutrition and EBV Persistence in Children
儿童微量营养素营养不良和 EBV 持续存在
- 批准号:
7431286 - 财政年份:2008
- 资助金额:
$ 48.92万 - 项目类别:
Micronutrient Malnutrition and EBV Persistence in Children
儿童微量营养素营养不良和 EBV 持续存在
- 批准号:
7791368 - 财政年份:2008
- 资助金额:
$ 48.92万 - 项目类别:
Antiangiogenic Therapy for AIDS-Associated Lymphomas
艾滋病相关淋巴瘤的抗血管生成治疗
- 批准号:
7284041 - 财政年份:2007
- 资助金额:
$ 48.92万 - 项目类别:
Antiangiogenic Therapy for AIDS-Associated Lymphomas
艾滋病相关淋巴瘤的抗血管生成治疗
- 批准号:
7414557 - 财政年份:2007
- 资助金额:
$ 48.92万 - 项目类别:
Effects of Malaria on EBV Persistence in Children
疟疾对儿童 EBV 持久性的影响
- 批准号:
8513935 - 财政年份:2005
- 资助金额:
$ 48.92万 - 项目类别:
Effects of Malaria on EBV Persistence in Children
疟疾对儿童 EBV 持久性的影响
- 批准号:
7986999 - 财政年份:2005
- 资助金额:
$ 48.92万 - 项目类别:
Effects of Malaria on EBV Persistence in Children
疟疾对儿童 EBV 持久性的影响
- 批准号:
7090089 - 财政年份:2005
- 资助金额:
$ 48.92万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 48.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 48.92万 - 项目类别:
Standard Grant














{{item.name}}会员




